6 stories tagged with #apogee-therapeutics, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.
⌘ RSS feed for this tag → or search "Apogee Therapeutics"
RELATED TAGS
SEEKING ALPHA
Apogee Therapeutics, Inc. (APGE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Apogee Therapeutics, Inc. (APGE) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 10, 2026 9:20 AM EDTCompany ParticipantsJane Pritchett...…
SEEKING ALPHA
Apogee Therapeutics: Charging Toward Pivotal Eczema Trial With Extended Dosing
Apogee Therapeutics, Inc. rated Buy: zumilokibart Phase 2b AD results, 2–4 doses/yr, Blackstone $1.3B funding; fair value $82.97—read now. Click for an APGE update.…
INVESTING.COM — NEWS
Apogee Therapeutics secures $1.3 billion Blackstone financing deal, shares dive
YAHOO FINANCE
Apogee Therapeutics Shares Surge Following $1.3 Billion Blackstone Financing Partnership (APOG)
INVESTING.COM — NEWS
Apogee Therapeutics shares jump on $1.3B Blackstone deal
SEEKING ALPHA
Apogee Therapeutics: Targeting Atopic Dermatitis
Apogee Therapeutics, Inc. is rated a Hold, driven by promising data for the lead asset zumilokibart in atopic dermatitis. Read more on APGE stock here.…